Podcasts about Cooperative

Mitch Bruneel serves as President of Retail Operations at Gill's Point S Tire, where he focuses on employee development, customer experience, and operational growth within a family business rooted in the tire industry for generations. His leadership reflects a commitment to collaborative learning and the shared culture that defines the Point S dealer community.Walter Lybeck is CEO of Point S Tire USA, helping lead the cooperative's national growth strategy, dealer branding initiatives, and member support programs. His leadership emphasizes collaboration, family-driven culture, and leveraging collective scale to strengthen independent tire dealers across the U.S.Patrick Lavoie oversees the retail network for Point S Tire Canada, supporting more than a thousand stores through operational programs, performance initiatives, and cross-market collaboration. Known for his competitive drive and focus on sales performance, he helps shape retail standards and growth strategies across the Canadian network.David Priddy owns David's Discount Tire in Oklahoma and has been an active Point S member for nearly a decade. With deep roots in the tire business, he emphasizes buying power, industry collaboration, and customer trust as key drivers behind sustained business growth and community reputation.Mickie Hall owns Point S American Tire in Gallup, New Mexico, stepping into leadership after inheriting the business unexpectedly. Through operational guidance, coaching programs, and strong team culture, she successfully expanded performance and profitability while honoring her family's legacy in the tire industry.Polo Rodriguez Jr. co-owns Rodriguez Point S Tire & Service in Texas and serves as Vice Chair of Point S Tire USA. He focuses on growth strategy, operational excellence, and industry leadership while advocating for customer-first values and collaborative dealer success across the network.Ron Preston owns Tredz Central Point S in Nebraska and brings decades of tire industry experience, including leadership in cooperative business models. His operations have seen consistent annual growth, supported by strong dealer relationships, shared best practices, and cooperative buying advantages.Nico De Rouwe is Managing Director of Point S South Africa, overseeing a large network of locations and championing collaborative business models that help independent dealers compete with major corporate chains. His leadership stresses international cooperation, long-term stability, and family-oriented business continuity.In this episode…Independent tire dealers face rising consolidation, aggressive national branding, and shifting customer expectations that demand consistency across locations. Standing alone limits leverage in purchasing, marketing, and operational benchmarking. Cooperative alignment continues reshaping how multi-location operators scale without sacrificing local identity.Recognition from Consumer Reports placing the network among the top tire retail experiences in the United States reinforces the impact of collaboration, operational standards, and shared brand equity. The Point S tire dealer network illustrates how collective strategy strengthens profitability, credibility, and long-term sustainability in a rapidly evolving automotive aftermarket.Here's a glimpse of what you'll learn: [01:27] Mitch Bruneel on operations, culture, and dealer collaboration[05:50] Walter Lybeck on cooperative growth and brand credibility[10:50] Patrick Lavoie on network scale and performance alignment[14:49] David Priddy on buying power and independent competitiveness[19:08] Mickie Hall on leadership transition and profitability growth[25:02] Polo Rodriguez Jr. on expansion goals and organizational direction[29:33] Ron Preston on annual business growth through cooperation[33:22] Nico De Rouwe on international dealer collaborationResources mentioned in this episode:Mitch Bruneel LinkedInWalter Lybeck LinkedInPatrick Lavoie LinkedInDavid's Discount Tires WebsitePoint S American Tire Gallup WebsiteRodriguez Point S Tire & Service WebsiteTredz Central Point S WebsiteNico De Rouwe LinkedInPoint S Tires WebsiteTread PartnersGain Traction Podcast on YouTubeGain Traction Podcast WebsiteMike Edge on LinkedInQuotable Moments:“Even though we're, you know, hundreds of miles apart, we all have the, you know, same goals, the same ideas.“My goal is to finish one, number one, for sure. So I will do anything to accomplish that goal.”“So to me, joining a company like Point S gave me the assurance that my sons will be all right, even if something happens to me.”“Buying power is probably the best part of being cooperative.”“Our business has grown about 30% a year.”Action Steps:Assess cooperative affiliations such as the Point S tire dealer network to increase buying leverage, operational support, and national brand credibility.Standardize customer experience processes across all locations to strengthen trust, improve retention, and elevate brand perception.Leverage peer networks for benchmarking, shared insights, and leadership development to accelerate performance improvements.Invest in operational coaching and financial performance reviews to identify profit leakage and drive measurable growth.

Peacewarts: Dept. of Living Roots - The Lie of Independence (Class 13) We deconstruct the myth of self-sufficiency. Through the "Cowboy Myth," the global standards of the ICAO, the industrial success of Mondragon, and the history of the Siege of Sarajevo (1992-1996), we learn why structural interdependence is more durable than isolation. Homework: Look up the Mondragon Corporation's list of products or the Haudenosaunee clans to see how they distribute roles. Write down one question about any of this episode's topics. If you don't have a question, write “no question.” Optional: Journal for five minutes. If you were a "Marlboro Man" in your own life, what would be the first thing to break if you got sick? Who would you have to call?   Learning Topics: The "Cowboy Myth" and its ecological/social impact; Logistical Entanglement: The ICAO flight standards; Mondragon (1956): Cooperative industrial interdependence; Haudenosaunee Great Law of Peace (c. 1142); Resilience vs. Isolation: Lessons from Sarajevo. Get the book Peace Stuff Enough: AvisKalfsbeek.com/peace-stuff-enough Join the Community / Get the Books: www.AvisKalfsbeek.com Podcast Music: Javier Peke Rodriguez “I am late, madame Curie” https://open.spotify.com/artist/3QuyqfXEKzrpUl6b12I3KW

For this episode of the A is for Architecture Podcast, Amica Dall, co-founder of Assemble, writer and researcher, and Frances Northrop, head of community economic power at the New Economics Foundation and a director of Totnes Community Development Society discuss Common Treasures (Vol. 1 & 2), published by Little Toller Books in 2025.Common Treasures was founded in 2025 by members & collaborators of Assemble to explore challenges in rural communities through practical, grassroots responses. Its aim is to enable rural communities, landowners, housing providers, and local authorities to achieve better shared outcomes for the people living and working there, and the land they live on. The books documents emerging conversations exploring alternative approaches to rural housing, land, food systems, and livelihoods.It's spatial, programmatic, projective, social and organisational, and as such it's designerly. So we talk about some of that.Socially, Amica can be gotten on LinkedIn and via Assemble. Frances is more distributed, electronically, and can be found on the NEF site, on LinkedIn and Instagram. +Music credit: ⁠Bruno GillickImage credit: ⁠Kaye Song⁠#ArchitecturePodcast #RuralFutures #AlternativeRuralHousing #CommonTreasuresBook #CommunityLedDesign

Episode 90 - Male enhancement procedures can lead to complications if patients lack proper care, including physical and emotional issues and the need for corrective surgeries. Poor pre- or post-operative care raises the risk of infection, scarring, and ongoing health problems. MSO speaks with Dr. Joel Pash, co-founder and medical director of Upsize clinic in San Francisco, about these challenges that give men a “hard time”.You can learn more about Dr. Joel Pash and the Upsize clinic at: https://www.upsizematters.com. Also, on his social media at: Instagram, TikTok, Twitter and YouTube. Another great show!Send a textMen Speaking Out...Talking to reveal, not conceal! menspeakingout.com

KPIs, NPS, churn—oh my! Data doesn't have to be daunting. Ty Houglum, CIO at ECE Fiber, shares how his team turns numbers into action, building a culture that makes data meaningful, not mysterious.Notes: Filmed at Calix ConneXions conference.

In this episode, P J and Adam discuss the fascinating world of cooperative board games, exploring their history, evolution, and the dynamics of teamwork involved in gameplay. They share personal experiences and insights into the mechanics of cooperative games, including the challenges of table captaining and the importance of communication. The conversation culminates in a list of their top five cooperative game recommendations, highlighting the fun and engaging aspects of playing together against the game itself.

Psst... Scroll for the link to my book on emotionally intelligent parenting! What if parenting didn't have to rely on punishment, guilt, or constant power struggles? Yep. Really.Today I'm actually the one being interviewed! My friend Amy Nesbitt had me on her podcast, Whole Wellness Mamas, and we unpacked what emotional intelligence parenting really means, and why it's so different from the old-school approaches many of us were raised with. This is the conversation you get to hear today!Amy and I talk about:Why punishing “bad behaviour” is SO outdated, and what actually helps kids become cooperativeHow honouring children's emotions builds connection, trust, and resilienceWhat it looks like to model emotional regulation instead of expecting kids to “just calm down”The power of rupture and repair, taking responsibility, apologising, and rebuilding connectionWhy emotional intelligence parenting takes intention and discipline, but works for so many familiesHow parents can start noticing their own emotional cycles BEFORE reactingExpanding your emotional vocabulary so you can respond, not explodeLINK FOR MY BOOK: If this way of thinking resonates, my book on Amazon goes deeper into these ideas — emotional intelligence as the foundation for calmer, more connected parenting. Think of it as a companion to this conversation.

On January 26th the Idaho statehouse was flooded with a sea of blue FFA jackets as part of the Cenarrusa FFA Day on the Hill.

I spoke to Tan Zhi Xuan, Assistant Professor at the National University of Singapore's Department of Computer Science and founder of the Cooperative Intelligence and Systems Lab, a research group confronting the gap between the rationalist AI alignment discourse focused on superintelligence and what is actually happening.I had her on to talk about her work on cooperative AI (designing AI systems and institutions that promote beneficial cooperation among AI-empowered actors rather than conflict), her critique of techno-solutionist AI alignment approaches that ignore class interests and political economy, and how blockchain technologies might enable decentralized governance for a future of specialized AI agents. We also talk about the approach that Senator Bernie Sanders has taken recently in his critiques of AI companies.This episode is sponsored by NYM, the world's most private VPN. Unlike traditional VPNs, Nym uses a decentralized mixnet to scramble your internet data — hiding who you're talking to, when, and how often. You can switch between full mixnet mode for maximum anonymity, or a faster VPN mode for everyday use.Use the code blockchainsocialist when signing up and get an extra month!If you liked the podcast be sure to give it a review on your preferred podcast platform. If you find content like this important consider donating to my Patreon starting at just $3 per month. It takes quite a lot of my time and resources so any amount helps. Follow me on Twitter (@TBSocialist) or Mastodon (@theblockchainsocialist@social.coop) and join the r/CryptoLeftists subreddit. Support the showICYMI I've written a book about, no surprise, blockchains through a left political framework! The title is Blockchain Radicals: How Capitalism Ruined Crypto and How to Fix It and is being published through Repeater Books, the publishing house started by Mark Fisher who's work influenced me a lot in my thinking. The book is officially published and you use this linktree to find where you can purchase the book based on your region / country.

Send us a textHiring a contractor shouldn't feel like a risky gamble—especially when you're spending association funds and hoping for a great result for your repair or renovation project. On this week's episode of Take It To The Board, host Donna DiMaggio Berger talks to Cinthya Lavin, VP of Communications and Community Engagement at the Better Business Bureau, to uncover practical and attainable ways Condominium, Cooperative and HOA boards can hire smarter, avoid scams, and build a reliable vendor bench without slowing projects to a crawl.  Cinthya breaks down how BBB's e-quote tool helps boards get three accredited bids—often within a day—so you can meet competitive bidding requirements and keep momentum on key repairs and capital projects.  Donna and Cinthya dig into what “accredited” really means, how BBB verifies licenses and insurance, and how the ratings algorithm weighs responsiveness, scale, complaint patterns, and government actions. You'll learn why a vendor's willingness to answer complaints often predicts how they'll handle issues on your job, and why communication should be a top selection criterion alongside price and scope.  They also explore the evolving threat landscape. BBB's Scam Tracker offers a community-wide alert system for fraud attempts, and Cinthya shares simple safeguards for boards. This episode also includes a comparison of BBB with platforms like Yelp; discusses AI's role in business education and reviews, and highlights programs such as the Torch Awards which celebrate companies with strong character, culture, customer care, and community impact.  If you want to make faster, safer hiring decisions and elevate trust in your community, this conversation delivers the playbook.Conversation Highlights:  Why a 100+-year-old organization is still relevant in today's fast-moving business landscapeHow the BBB evaluates businesses and what really separates an A+ rating from a lower gradeHow boards and managers can use the BBB to vet contractors and comply with competitive bidding requirementsHow to identify complaint trends and spot vendors with recurring unresolved issues.Listed vs. accredited: The key differences between businesses that appear on the BBB and those that earn accreditation.Warning signs on a BBB profile, from licensing issues to unresolved disputes and suspicious business details.How the BBB can help confirm insurance, licensing, and other critical qualifications.What the BBB is seeing in post-storm reconstruction—and the rise of scams and fraudulent contractors.One simple step boards can take today to reduce vendor risk and protect their communitiesRelated Links:Podcast: Why Every Contract Needs to Be Reviewed with Becker's James Robert CavesResource: Consumer Resources from The Better Business BureauArticle: Am I Protected? Contractual Quandaries for All Associations

In celebration of Black History Month and Heart Health Month, we're re-airing our powerful conversation with Dr. Gabrielle Williams, founder of Gateway Direct Health in Georgia. Dr. Williams shares her inspiring journey from severe burnout in fee-for-service medicine where she dreaded waking up each morning to discovering Direct Primary Care as her "second chance into medicine." As the first person in her family to attend college, she went on to become a board-certified family physician who now practices medicine on her own terms. In this episode, Dr. Williams candidly discusses the personal and spiritual growth required in that crucial first year of entrepreneurship, the importance of healing from healthcare trauma, and why her patients, even those with insurance, choose her practice for the irreplaceable value of time, trust, and a genuine doctor-patient relationship. Her story embodies the resilience and possibility that emerges when physicians of color build sustainable, community-rooted practices, and serves as both inspiration and practical guidance for anyone considering the DPC path.Learn how Zion HealthShare can pair with DPC to protect patients and physicians without returning to traditional insurance. Read more in the Toolkit, our DPC magazine, today.  If hiring feels like one of the most intimidating parts of growing your DPC practice, read the Winter issue of The Toolkit, our DPC Magazine that includes an educational, step-by-step hiring guide from the Cooperative of American Physicians designed to replace guesswork with clarity. What do you want MORE of in your practice this year? Download the January worksheet HERE for free today!Support the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOAD Become A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

The Church: is Not a Building but is a Building Project, is Universal and Local, is Visible and Invisible, is True or False, is Redeemed and Regenerate, is Gathered and Scattered, is Autonomous and Cooperative, is Elder-led and Congregational, is Accountable and Reconciling, performs baptism and the Lord's Supper, is Militant and Triumphant, Worships and Witnesses, gathers for Preaching and Prayer, is Holy and Hospitable, and is Meager and Glorious.

I recently learned that the name “CARE” package came from the acronym for “Cooperative for American Remittances to Europe,” a group that sent boxes of food to help Europeans displaced during World War II. While the care packages I send my kids at college are mostly filled with homemade treats and candy, they usually include a few practical items—a favorite shirt forgotten at home or extra school supplies. While the name “care package” may be modern, the practice of sending helpful items is far older. It’s even tucked away at the end of 2 Timothy. Writing while imprisoned in Rome, Paul concluded his letter to his trusted disciple with some personal requests. He asked that Timothy come and bring Mark to help him (v. 11). Then he requested some personal items: his cloak and his “scrolls, especially the parchments” (4:13). Perhaps the cloak was needed because winter was coming, and maybe the scrolls contained copies of the Old Testament. Whatever the reason, Paul longed for companionship and practical items to refresh and encourage him. Tangible reminders of care, whether the recipient lives near or far, can have a significant impact on someone in need of a little encouragement. The gift of a meal for a neighbor, a thoughtful card written to a loved one or acquaintance, or a package full of goodies sent to a faraway friend can extend God’s love in practical ways.

A blank page can be scary—unless you already know what you're writing. In this episode, Mt. Wheeler Power's Christina Sawyer shares how using AI to brainstorm story ideas at the start of the year gave her more time to research, write with confidence and even inspire other utilities through the Ruralite share package.Notes: Filmed at NWPPA's Northwest Innovations in Communications conference.

Governor Beshear says at least three deaths may be tied to winter storm, Kentucky getting support from outside to help restore power to thousands, Northern Kentucky sets another snowfall record, and Republican congressman James Comer of Kentucky says it might be time for ICE to leave Minneapolis.

There’s a political battle underway over health care subsidies, and it’s leaving rural Wisconsin at a crossroads. Here with some perspective is Ben Nelson, the new executive director of the Cooperative Network. CN is the trade association that supports cooperatives across Wisconsin and Minnesota across all sectors, including agriculture, energy, and rural economic development. Ben has a 20-year career behind him in the economic growth space, most of that time in Wisconsin. He actually grew up on a deer farm, but most recently, he was the executive director of the Kewaunee County Economic Development Corp. Before Ben and Stephanie Hoff dive into what exactly is going on with the Affordable Care Act, he tells us what drew him to this role at CN. After the conversation, Ben says while the deadline for healthcare.gov may have passed, you can still audit your 2026 options. Consider a Health Savings Account to manage those high deductibles, or run your income numbers carefully to avoid the 'subsidy cliff,' as he calls it. In the meantime, he says the Cooperative Network is working to reopen the Farmers Health Cooperative.See omnystudio.com/listener for privacy information.

Most physicians are trained to manage what's in front of them.What we're rarely taught is how to step far enough back to ask whether the direction itself still makes sense.In this January Reset re-air, I'm bringing back my conversation with Dr. Neal Douglas, a family medicine physician at Heritage Family Medicine in Hood River, Oregon.Dr. Douglas shares openly about building a successful career that slowly drifted out of alignment with his life, his family, and his values. His story isn't about optimizing productivity — it's about reordering priorities and designing a practice that supports the life he wants to be present for.You'll hear how creating a clear priority list reshaped not just his work, but his sense of fulfillment and sustainability as a physician. This episode pairs especially well with the January worksheet reflections on career direction, energy, and long-term alignment.If you've been asking yourself whether your current path still fits, this conversation offers perspective without pressure.January Reset Invitation Download the free January worksheet, Is DPC Right for You?, and use it to name where you are on the ladder — burnout, curiosity, relief, or alignment.Get the FREE workbook to go along with our January RESET series HERE. Learn how Zion HealthShare can pair with DPC to protect patients and physicians without returning to traditional insurance. Read more in the Toolkit, our DPC magazine, today.  If hiring feels like one of the most intimidating parts of growing your DPC practice, read the Winter issue of The Toolkit, our DPC Magazine that includes an educational, step-by-step hiring guide from the Cooperative of American Physicians designed to replace guesswork with clarity. What do you want MORE of in your practice this year? Download the January worksheet HERE for free today! Leave Maryal a voicemail @ https://mydpcstory.com/contactSupport the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOAD Become A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Episode 89Preventing human trafficking involves raising awareness, strengthening laws, and supporting vulnerable communities to stop exploitation before it starts. At the same time, addressing porn addiction requires education, access to support resources, and fostering healthy relationships. Together, these efforts empower individuals and communities to protect themselves and others from harm. Join me as MSO interview's Joe Madison, Executive Director of Demand Disruption (https://demanddisruption.org/) to discuss these society challenges that impact us all! More of Demand Disruption can be followed at: Podcast, Instagram, YouTube, and FaceBook.Lastly Congratulations to Deman Disruption celebrating their 10th year in fighting human trafficking. Much love from MSO!Send us a textMen Speaking Out...Talking to reveal, not conceal! menspeakingout.com

How do we identify the individuals in our lives who leave us feeling drained, diminished, or overwhelmed. Whether it's friends, co-workers, or even family members, they are ALL quite capable of doing so. So how do we handle it? Join MSO as we speak with Coach/Author Daniel Ratner as we discuss his new book " Emotional Vampires: How to Protect Your Happiness From People Who Suck Yours Dry". I found it to be filled with a ton of valuable information.It was an awesome show you want to tune in. Daniel Ratner's Social Media Links Below: Website, Instagram, Twitter, YouTube, TikTok and LinkedIn. Send us a textMen Speaking Out...Talking to reveal, not conceal! menspeakingout.com

As a writer on shows like Paw Patrol, Spirit Rangers and Cocomelon Lane, Joey Clift shares some of the keys to reaching the youngest audiences. Joey will be a speaker at StoryConnect 2026.

Fonterra has new plans to expand. It's bringing its organics business to the South Island, inviting farmers to join, with certification and processing targeted for 2028. Around 100 farms are already involved in the North Island programme as global demand continues to grow – driven by the US, China, and Europe. Fonterra Co-operative Council Chair John Stevenson told Mike Hosking the key will be for Fonterra to grow at a rate where the demand doesn't get swamped. But, he says, it's a really good news story for their farmers down south. LISTEN ABOVE See omnystudio.com/listener for privacy information.

Not all misalignment shows up as exhaustion.Sometimes medicine works - the protocols are correct, the outcomes are acceptable - and yet something essential feels missing.In this January Reset re-air, I'm revisiting my conversation with Dr. Meena Julapalli, a pediatric dermatologist whose work spans direct care, creativity, and healing.Dr. Julapalli speaks honestly about practicing inside systems that prioritize efficiency and algorithms, and what gets lost when time, presence, and relationship are squeezed out of care. Her story isn't about leaving medicine - it's about reclaiming it.You'll hear how creating space for meaning and connection changed the way she experiences her work, her patients, and herself as a physician. This conversation aligns deeply with the January Reset reflections around energy, sustainability, and patient relationships.If you've ever felt that your current version of medicine is technically sound but emotionally incomplete, this episode may land close to home.January Reset Invitation Use this episode alongside the free January worksheet, Is DPC Right for You? After listening, answer one question: Where do I want more presence or meaning in my work this year?Get the FREE workbook to go along with our January RESET series HERE. Learn how Zion HealthShare can pair with DPC to protect patients and physicians without returning to traditional insurance. Read more in the Toolkit, our DPC magazine, today.  If hiring feels like one of the most intimidating parts of growing your DPC practice, read the Winter issue of The Toolkit, our DPC Magazine that includes an educational, step-by-step hiring guide from the Cooperative of American Physicians designed to replace guesswork with clarity. What do you want MORE of in your practice this year? Download the January worksheet HERE for free today! Leave Maryal a voicemail @ https://mydpcstory.com/contactSupport the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOAD Become A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Recorded live at CiderCon, this episode brings listeners into a rare, in-depth conversation about Chile's living cider tradition—one shaped by more than 450 years of apple fermentation, deep regional biodiversity, and community-based agriculture. Moderated by Eli Shanks, this panel features cider makers, cooperative leaders, and academics from southern Chile who explore how apples arrived, adapted, and endured across Araucanía, Los Ríos, and the Chiloé archipelago. Rather than a "new" cider movement, Chile offers something far rarer: a cider culture that never disappeared. At the heart of the discussion is Chicha—the traditional name for fermented apple beverages in Chile—and the cultural weight that language carries. Panelists unpack how Chicha and cider share the same roots, why heritage orchards matter, and what's at stake as aging farmers, development pressure, and climate change threaten seed-grown apple diversity. Listeners will also hear about: Heritage apple orchards over 100 years old, many grown from seed The role of women as primary stewards of orchards and biodiversity Native fermentation vessels made from Raulí and other Chilean woods Cooperative cider making on the island of Chiloé The challenges of valuing cider beyond "cheap, rural" perceptions The future of Chilean cider on the global stage, including education, competitions, and potential export This episode offers an essential perspective for anyone interested in cider as culture—not trend—and in how place, people, and history shape what ends up in the glass. Panelists & Contributors Eli Shanks – Co-founder, Punta de Fierro Fine Cider; Head Cider Maker, Western Cider Gicella – President, Cooperative Chilwe (Chiloé) René Galindo – Third-generation cider maker, Araucanía Carlos Flores – Co-founder, Punta de Fierro Fine Cider; Orchardist, Valdivia Fabián Lara – Cider & beer consultant; INDAP (Chilean Ministry of Agriculture) José Antonio Aldea – Professor and fermentation educator Key Themes Chilean cider and Chicha traditions Heritage apple orchards and seed-grown ecotypes Women's roles in orchard preservation Cooperative models and island agriculture Native materials and spontaneous fermentation Preserving cider culture in a changing landscape Timestamps ⏱️ Detailed timestamps are listed above to help you jump to specific topics, speakers, and cider discussions. 00:00 Introduction to Chicha and Cider 00:26 News Out and About  Ciderville  00:43 Episode Overview: Chilean Cider Panel 03:30 Upcoming Events and Announcements 07:42 Introduction to the Chilean Panel 10:44 Chilean Cider Regions and History 16:11 Traditional Cider Making in Chile 18:11 Modern Chilean Cider and Future Prospects 20:16 Cider Tasting and Panel Discussion 29:32 Consumer Perception of Cider in Chile 30:07 Challenges and Efforts in Differentiation 30:34 Traditional and New World Ciders 31:13 Exciting Apple Varieties and Characteristics 32:19 Naming and Regional Varieties 35:40 Incorporating Local Fruits into Cider 38:09 Historical Context and Apple Lineages 41:47 Fire Blight and Disease Resistance 42:57 Modern vs. Traditional Cider Making 44:15 Collaborations with Winemakers 47:12 Preserving Heritage Apple Orchards 52:10 Forming a Cooperative in Chiloé 54:53 Market Development and Sales Strategies 57:03 Generational Gaps and Preservation Efforts 59:08 Future Goals and International Connections Support Cider Chat® If you value independent, long-form conversations that preserve cider history and amplify global voices, consider supporting Cider Chat® on Patreon. Your support helps keep these stories accessible and the podcast on the air.  

In this episode of the Finovate Podcast, host Greg Palmer connects with Brent Biernat, Senior Vice President and Chief Operating Officer at COCC, a finalist in the Finovate Awards for Best Back Office Solution and Executive of the Year. Brent shares his journey of over 30 years with COCC, highlighting his passion for community banking and the company's mission to support small businesses and consumers. COCC, a core and digital banking services provider for over 150 clients in the Northeast, operates under a unique cooperative structure that fosters long-term vision and prioritizes customer needs over short-term profitability. Brent delves into the advantages of COCC's cooperative model, which ensures that all shareholders are active customers and board members are CEOs of financial institutions. This structure promotes trust, transparency, and open communication, allowing COCC to tailor its technology and services to meet the specific needs of each institution. Brent emphasizes the importance of building strong relationships with customers, where mutual understanding and collaboration lead to better outcomes. He also discusses how COCC's Strategic Development Council and regular executive visits help maintain alignment with customer goals and ensure continuous improvement. The episode also highlights COCC's recent recognition in the American Bankers Association (ABA) survey, where it ranked number one across multiple categories, including service, technology, and contract fairness. Brent shares insights on the importance of fully utilizing technology and maintaining transparent, long-term partnerships. He offers advice to financial institutions evaluating core relationships, encouraging them to prioritize adaptability, trust, and shared growth. This engaging conversation underscores the value of collaboration and innovation in the fintech and banking sectors. More info: COCC: https://www.cocc.com/ ; https://www.linkedin.com/company/cocc/ Brent Biernat: https://www.linkedin.com/in/brent-biernat-b542bb/ Greg Palmer: https://www.linkedin.com/in/gregbpalmer/ Finovate: https://www.finovate.com;https://www.linkedin.com/company/finovate-conference-series/ Finovate Awards: https://informaconnect.com/finovate-industry-awards/ #Finovate #COCC #Banking #CreditUnions #banks #finovateawards #awardsfinalist #digitalbanking #podcast #fintechpodcast #financialservices #innovation #backoffice #ai #digitraltransformation #fintech #finserv #modernization #innovation #communitybanking

From teaching 95-year-olds to stream their favorite shows to connecting the 5,000th home to fiber, Beacon Broadband proves inclusion and innovation go hand in hand. Bill Gerski shares how their Connected Senior Program bridges generations and the ways other Utility Pioneers can replicate the success in their own communities.Notes: Filmed at Calix ConneXions conference.

Dr. Hope Rugo and Dr. Vivek Subbiah discuss innovative trial designs to enable robust studies for smaller patient populations, as well as the promise of precision medicine, novel therapeutic approaches, and global partnerships to advance rare cancer research and improve patient outcomes. TRANSCRIPT  Dr. Hope Rugo: Hello and welcome to By the Book, a podcast series from ASCO that features engaging conversations between editors and authors of the ASCO Educational Book. I am your host, Dr. Hope Rugo. I am the director of the Women's Cancers Program and division chief of breast medical oncology at the City of Hope Cancer Center [in Los Angeles]. The field of rare cancer research is rapidly transforming thanks to progress in clinical trials and treatment strategies, as well as improvements in precision medicine and next-generation sequencing that enable biomarker identification. According to the National Cancer Institute, rare cancers occur in fewer than 150 cases per million each year, but collectively, they represent a significant portion of all cancer diagnoses. And we struggle with the appropriate treatment for these rare cancers in clinical practice. Today, I am delighted to be joined by Dr. Vivek Subbiah, a medical oncologist and the chief of early-phase drug development at the Sarah Cannon Research Institute in Nashville, Tennessee. Dr. Subbiah is the lead author of a paper in the ASCO Educational Book titled "Designing Clinical Trials for Patients with Rare Cancers: Connecting the Zebras," a great title for this topic. He will be telling us about innovative trial designs to enable robust studies for small patient populations, the promise of precision medicine, and novel therapeutic approaches to improve outcomes, and how we can leverage AI now to enroll more patients with rare cancers in clinical trials. Our full disclosures are available in the transcript of this episode.  Dr. Subbiah, it is great to have you on the podcast today. Thanks so much for being here. Dr. Vivek Subbiah: Thank you so much, Dr. Rugo, and it is an honor and pleasure being here. And thank you for doing this podcast for rare cancers. Dr. Hope Rugo: Absolutely. We are excited to talk to you. And congratulations on this fantastic paper. It is such a great resource for our community to better understand what is new in the field of rare cancer research. Of course, rare cancers are complex and multifaceted diseases. And this is a huge challenge for clinical oncologists. You know, our clinics, of course, cannot be designed as we are being very uni-cancer focused to just be for one cancer that is very rare. So, oncologists have to be a jack of all trades in this area. Your paper notes that there are approximately 200 distinct types of rare and ultra-rare cancers. And, by definition, all pediatric cancers are rare cancers. Of course, clinical trials are essential for developing new treatment strategies and improving patient outcomes, and in your paper, you highlight some unique challenges in conducting trials in this rare cancer space. Can you tell us about the challenges and how really innovative trial designs, I think a key issue, are being tailored to the specific needs of patients with rare cancer and, importantly, for these trials? Dr. Vivek Subbiah: Rare cancers present a perfect storm of challenges. First, the patient populations are very small, which makes it really hard to recruit enough participants for traditional type trials. Second, these patients are often geographically dispersed across multiple cities, across multiple states, across multiple countries, across multiple zip codes. So, logistics become complicated. Third, there is often limited awareness among clinicians, which delays referrals and diagnosis. Add to that regulatory hurdles, funding constraints, and you can see why rare cancer trials are so tough to execute. To overcome these barriers, we are seeing some really creative novel trial designs. And there are four different types of trial designs that are helping with enrolling patients with rare cancers. The first one is the basket trial. So let us talk about what basket studies are. Basket studies group patients based on shared genetic biomarkers or shared genetic mutations rather than tumor type. So instead of running separate 20 to 30 to 40 trials, you can study one therapy across multiple cancers. The second type of trial is the umbrella trial. The umbrella trials flip that concept of basket studies. They focus on one cancer type but test multiple targeted therapies within it. The third category of innovative trials are the platform studies. Platform trials are another exciting innovation. They allow new treatment arms to be added or removed as the data matures and as the data evolves, making trials more adaptive and efficient. The final category are decentralized tools in traditional trials, which are helping patients participate closer to where they are so that they can sleep in their own bed, which is, I think, a game changer for accessibility.  These designs maximize efficiency and feasibility for rare cancer research and rare cancer clinical trials. Dr. Hope Rugo: I love the idea of the platform trials that are decentralized. And I know that there is a trial being worked on with ARPA-H (Advanced Research Projects Agency for Health) funding in triple-negative breast cancer as well as in lung cancer, I think, and others with this idea of a platform trial. But it is challenged, I think, by precision medicine and next-generation sequencing where some patients do not have targetable markers, or there isn't a drug to target the marker. I think those are almost the same thing. We have really seen that these precision medicine ideas and NGS have moved the needle in helping to identify genetic alterations. This helps us to be more personalized. It actually helps with platform studies to customize trial enrollment. And we hope that this will result in better outcomes. It also allows us, I think, to study drugs even in the early stage setting more effectively. How can these advances be best applied to the future of rare cancers, as well as the challenges of not finding a marker or not having a drug? Dr. Vivek Subbiah: Thank you so much for that question. I think precision medicine and next-gen sequencing, or NGS, are truly the backbone of modern precision oncology. They have transformed how we think about cancer treatment. Instead of treating based on where the tumor originated or where the tumor started, we now look at the genetic blueprint of cancer. The NGS or next-gen sequencing allows us to sequence millions of DNA fragments quickly. Twenty, 30 years ago, they said we cannot sequence a human genome. Then it took almost a decade to sequence the first human genome. Right now, we have academic centers and commercial sequencing companies that are really democratizing NGS across all sites, not just in academic centers, across all the community sites, so that NGS is now accessible. This means that we can identify these actionable alterations like picking needles in haystacks, like NTRK fusions, RET fusions, or BRAF V600E alterations, high tumor mutational burden. This might occur across not one tumor type, across several different tumor types. So for rare cancers, this is critical because some of these mutations often define the best treatment option. Here is why this matters. Personalized therapy, right? Instead of a one-size-fits-all approach, we can tailor treatment to the patient's unique molecular profile. For trial enrollment, this can definitely help because patients can join biomarker-driven trials even if their cancer type is rare or ultra-rare. NGS technology has also helped us in designing rational studies. Many times monotherapy does not work in these cancers. So we are thinking about rational combination strategies. So NGS technology is helping us. Looking ahead, I see NGS becoming routine in clinical practice, not just at major niche academic centers, but everywhere. We will see more tumor-agnostic approvals, more molecular tumor boards guiding treatment decisions in real time. And I think we are seeing an expanded biomarker setup. Previously, we used to have only a few drugs and a handful of mutations. Now with homologous recombination defects, BRCA1/2 mutation, and expanding the HRD and also immunohistochemistry, we are expanding the biomarker portfolio. So again, I personally believe that the future is precision. What I mean by precision is delivering the right drug to the right patient at the right time. And for rare cancers, this isn't just progress. It is survival. And it is maybe the only way that they can have access to these cutting-edge precision medicines. Dr. Hope Rugo: That is so important. You mentioned an important area we will get to in a moment, the tumor-agnostic therapies. But as part of talking about that, do you think that the trials should also include just standard therapies? You know, who do you give an ADC to and when with these rare cancers? Because some of them do not have biomarkers to target and it is so disappointing for patients and providers where you are trying to screen a patient for a trial or a platform trial where you have one arm with this mutation, one arm with that, and they do not qualify because they only have a p53 loss, you know? They just do not have the marker that helps them. But we see this in breast cancer all the time. And it is tough because we don't have good information on the sequencing. So I wonder, you know, just because for some of these rare cancers it is not even clear what to use when with standard treatments. And then that kind of gets into this idea of the tumor-agnostic therapies that you mentioned. There are a lot of new treatments that are being evaluated. We have seen approval of some treatments in the last few years that are tumor-agnostic and based on a biomarker. Is that the best approach as we go forward for rare cancers? And what new treatment options are most exciting to you right now? Dr. Vivek Subbiah: Tumor-agnostic therapies, really close to my heart, are real breakthrough therapies and represent a major paradigm shift in oncology. Traditionally, for the broad listeners here, we are used to thinking about designing clinical trials and therapy like where the cancer originated, breast cancer, kidney cancer, prostate cancer, lung cancer. A tumor-agnostic therapy flips that model. Instead of focusing on the organ, they target the specific genetic alteration or biomarker that drives cancer growth regardless of where the tumor started, regardless of the location of the tumor, regardless of the zip code of the tumor. So why is this so important for rare cancers? Because many rare cancers share molecular features with more common cancers. For instance, NTRK fusion might occur in pediatric sarcoma, a salivary gland tumor, or a thyroid cancer. Historically, each of these would require separate trials, which is nearly impossible, unfeasible to conduct in these ultra-rare cancers like salivary gland cancer or pediatric sarcomas. Tumor-agnostic therapies allow us to treat all those cancers with the same targeted drug if they share that biomarker. Again, we are in 2025. The first tissue-agnostic approval, the historic precedent, was in fact an immunotherapy. Pembrolizumab was approved in 2017, May 2017, as the first immunotherapy to be approved in a tumor-agnostic way for a genomic biomarker, for MSI-High and dMMR cancers. Then came the NTRK inhibitors. So today we have not one, not two, but three different NTRK inhibitors: larotrectinib, entrectinib, and repotrectinib, which show response rates of nearly more than 60 to 75% across a handful of dozens and dozens of cancer types. Then, of course, we have RET inhibitors like selpercatinib, which is approved tissue-agnostic, and pralsetinib, which also shows tissue-agnostic activity across multiple cancers. And more recently, combination therapy with a BRAF and MEK combination, dabrafenib and trametinib, received tumor-agnostic approval for all BRAF V600E tumors with the exception of colorectal cancer. And even recently, you mentioned about antibody drug conjugates. Again, I think we live in an era of antibody drug conjugates. And Enhertu, trastuzumab deruxtecan, which was used first in breast cancer, now it is approved in a histology-agnostic manner for all HER2-positive tumors defined by immunohistochemistry 3+. So again, beyond NGS, now immunohistochemistry for HER2 is also becoming a biomarker. So again, for the broad listeners here, in addition to comprehensive NGS that may allow patients to find treatment options for these rare cancers for NTRK, RET, and BRAF, immunohistochemistry for HER2 positivity is also emerging as a biomarker given that we have a new FDA approval for this. So I would say personally that these therapies are game changers because they open doors for patients who previously had no options. Instead of waiting for years for a trial in their specific cancer type, they can access a treatment based on their molecular profile. I think it is precision medicine at its finest and best. Looking ahead, the third question you asked me is what is exciting going on? I think we will see more of these approvals. My hope is that today, I think we have nine to ten approvals. My hope is that within the next 25 to 50 years, we will have at least 50 to 100 drugs approved in this space based on a biomarker, not based on a location of the tumor type. Drug targeting rare alterations like FGFR2 fusions, FGFR amplifications, ALK fusions, and even complex signatures like high tumor mutational burden. I think we will be seeing hopefully more and more drugs approved. And as sequencing becomes routine, we will identify more patients for these therapies. I think for rare cancers, this is not just innovative approach. This is essential for them to access these novel precision medicines. Dr. Hope Rugo: Yeah, that is such a good point. I do think it is critical. Interestingly in breast cancer, it hasn't been, you know, there is always like two patients in these tumor-agnostic trials, or if that. You know, I think I have seen one NTRK fusion ever. I think that highlights the importance for rare cancers. And you know, I am hoping that that will translate into some new directions for some of our rarer and impossible-to-treat subtypes of breast cancer. It is this kind of research that is really going to make a difference. But what about those people who do not have biomarkers? What if you do not fit into that? Do you think there is a possibility of trying to do treatments for rare cancers in some prospective way that would help with that? You know, it is really a huge challenge. Dr. Vivek Subbiah: Absolutely. I think, you know, you're right, usually many of these rare cancers are driven by specific biomarkers. And again, some of the pediatric salivary gland tumors or pediatric sarcomas like fibrosarcomas, they are pathognomonic with NTRK fusions. And again, given that we have a tumor-agnostic approval, now these patients have access to these therapies. And I do not think that we would have had a trial just for pediatric fibrosarcomas with NTRK fusions. So that is one way. Another way is SWOG, right? The SWOG DART [1609] had this combination dual checkpoint, it was called the DART study dual combination chemotherapy with ipi/nivo. Now here the rare cancer subtype itself becomes a biomarker and they showed activity across multiple rare cancer subtypes. They didn't require a biomarker. As long as it was a rare or ultra-rare cancer, these patients were enrolled into the SWOG DART trial and multiple arms have read out. Angiosarcoma, Kaposi sarcoma, even gestational trophoblastic disease. Again, they have shown responses in these ultra-rare, rare cancers. Sometimes they might be seeing one or two cases a whole year. And I think this SWOG effort, this cooperative group effort, really highlighted the need for such studies without biomarkers as well. Dr. Hope Rugo: That is such a fantastic example of how to try and treat patients in a collaborative way. And in the paper, you also emphasize the need for collaborative research efforts, you know, uniting resource expertise across different ways of doing research. So cooperative groups, advocacy organizations that can really help advance rare cancer research, improve access to new therapies, and I think importantly influence policy changes. I think this already happened with the agnostic approvals. Could you tell us more about that? How can we move forward with this most effectively? Dr. Vivek Subbiah: Personally, I believe that collaboration is absolutely critical and essential for rare cancer research. No single institution, no single individual, or no single state or entity can tackle these challenges alone. The patient populations are small and dispersed. So pooling resources is the only way to run these meaningful trials. Again, it is not like singing, it is like putting a huge, huge, I would say, an opera piece together. It is not a solo, vocal therapy, but rather putting a huge opera piece like Turandot. You know, you mentioned cooperative groups. Cooperative groups, as I mentioned earlier, the SWOG DART program, the ASCO [TAPUR study]. ASCO is doing a phenomenal work of the TAPUR study. Again, this ASCO TAPUR program has enrolled so many patients with rare cancers who otherwise would not have treatment options. NCI-MATCH, the global effort, right? NCI-MATCH and the ComboMATCH are great examples. They bring together hundreds of sites, thousands of clinicians to run large-scale trials that would be impossible for any individual center or institution. These trials have already changed practice. For instance, the DART demonstrated the power of immunotherapy in rare cancers and influenced NCCN guidelines. One of the arms of the NCI-MATCH study from the BRAF V600E arm contributed towards the BRAF V600E tissue-agnostic approval. So, the BRAF V600E tissue-agnostic approval was by a pooled analysis of several studies. The ROAR study, the Rare Oncology Agnostic Research study, the NCI-MATCH dataset of tumor-agnostic cohort, and another pediatric trial, and also evidence from literature and evidence of case reports. And all this pooled analysis contributed to the tissue-agnostic approval of BRAF V600E across multiple rare cancers. There are several patient advocacy organizations which are the real unsung heroes here. Groups like, for instance, we mentioned in the paper, Target Cancer Foundation, don't just raise awareness for rare cancer research, they actively connect patients to trials providing financial, emotional support, and even run their own studies like the TRACK trial. They also influence policy to make access easier. On a global scale, initiatives like DRUP in the Netherlands, the ROME study in Italy, the PCM4EU in Europe are expanding precision medicine across these borders. These collaborations accelerate research, improve trial enrollment, and ensure patients everywhere can have access to these cutting-edge therapies. Again, it is truly a team effort, right? It is a multi-stakeholder approach. Researchers, clinicians, investigators, industry, regulators, academia, patients, patient advocates, and their caregivers all working together. And it takes a village. Dr. Hope Rugo: Absolutely. I mean, what a nice response to that. And I think really exciting and it is great to see your passion about this as well. But it helps all of us, I think, getting discouraged in treating these cancers to understand what is happening moving forward. And I think it is also a fabulous opportunity for our junior colleagues as they rise up in academics to be involved in these international collaborative efforts which are further expanding. One of the things that comes up for clinical trials for patients, and I think it is highlighted with rare cancers because, as you mentioned, people are all over the place, you know, they are so rare. They are all far away. Our patients are always saying to us, "Should I go here for a phase 1 trial?" Can you talk a little bit about how we can overcome these financial and geographic burdens for the patients? You talked about having trials locally, but it is a big financial and just social burden for patients. Dr. Vivek Subbiah: Great point. Financial cost is a major barrier in rare cancer clinical trials. It is a major barrier not just in rare cancer clinical trials, but in clinical trials in general. The economics of rare cancer research are one of the toughest challenges we face. Developing a new drug is already expensive, often billions of dollars. On an average, it takes 2 billion dollars or 2.8 billion dollars according to some data from drug discovery to approval. For rare cancers, the market is tiny, which means the pharmaceutical companies have really little financial incentive to invest. That is why initiatives like the Orphan Drug Act were created to provide tax credits, grants, and market exclusivity to encourage development for rare diseases. Clinical trials themselves are expensive because the small patient populations mean longer recruitment times and higher per-patient costs. Geographic dispersion, as you mentioned, for the patients adds travel, coordination. That is why we need to think out of the box about decentralized trial infrastructure so that we can mitigate some of these expenses. Complex trial designs like basket or platform trials sometimes require sophisticated data systems and regulatory oversight. That is a challenge. And I think some of the pragmatic studies like ASCO TAPUR have overcome those challenges. Advanced technologies like next-gen sequencing and molecular profiling also add significant upfront cost to this. Funding is also limited because rare cancers receive less attention compared to common cancers. Public funding and cooperative group trials help a lot, but I think they cannot cover everything. Patient advocacy organizations sometimes step in to bridge these gaps, but sustainable financing remains a huge challenge. So, the bottom line is without financial incentives and collaborating funding models, many promising therapies for rare cancers would never make it to patients. That is why we need system-wide policy changes, global partnerships, and innovative, effective, seamless trial designs which are so critical so that they can help reduce the cost and make research feasible so that we can deliver the right drug to the right patient at the right time. Dr. Hope Rugo: There is a lot of excitement about the future integration of AI in screening. Just at the San Antonio Breast Cancer meetings, we have a number of different presentations about AI to find markers, even like HER2, and using AI where you would screen and then match patients to clinical trials. Do you have any guidance for the rare cancer community on how to leverage this technology in order to optimize patient enrollment and, I think, identification of the best treatment matches? Dr. Vivek Subbiah: I think artificial intelligence, AI, is a game-changer in the making. Right now, clinical trial is clunky. Matching patients to trial is often manual, time consuming, laborious. You need a lot of personnel to do that. AI can automate this process by analyzing genomic data, medical records, and trial eligibility criteria to find the best matches quickly, accurately, and effectively. For the community, the key is to invest in data standardization and interoperability because AI needs clean, structured data to work effectively. Dr. Hope Rugo: Thank you so much, Dr. Subbiah, for sharing these fantastic insights with us on the podcast today and for your excellent article. Dr. Vivek Subbiah: Thank you so much. Dr. Hope Rugo: We thank you, our listeners, for joining us today. You will find a link to Dr. Subbiah's Educational Book article in the transcript of this episode. And please join us again next month on By the Book for more insightful views on key issues and innovations that are shaping modern oncology.  Thank you. Disclaimer: The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Follow today's speakers:        Dr. Hope Rugo   @hoperugo   Dr. Vivek Subbiah @VivekSubbiah Follow ASCO on social media:        ASCO on X  ASCO on Bluesky       ASCO on Facebook        ASCO on LinkedIn        Disclosures:       Dr. Hope Rugo:    Honoraria: Mylan/Viatris, Chugai Pharma   Consulting/Advisory Role: Napo Pharmaceuticals, Sanofi, Bristol Myer   Research Funding (Inst.): OBI Pharma, Pfizer, Novartis, Lilly, Merck, Daiichi Sankyo, AstraZeneca, Gilead Sciences, Hoffman La-Roche AG/Genentech, In., Stemline Therapeutics, Ambryx   Dr. Vivek Subbiah: Consulting/Advisory Role: Loxo/Lilly, Illumina, AADI, Foundation Medicine, Relay Therapeutics, Pfizer, Roche, Bayer, Incyte, Novartis, Pheon Therapeutics, Abbvie Research Funding (Inst.): Novartis, GlaxoSmithKline, NanoCarrier, Northwest Biotherapeutics, Genentech/Roche, Berg Pharma, Bayer, Incyte, Fujifilm, PharmaMar, D3 Oncology Solutions, Pfizer, Amgen, Abbvie, Mutlivir, Blueprint Medicines, Loxo, Vegenics, Takeda, Alfasigma, Agensys, Idera, Boston Biomedical, Inhibrx, Exelixis, Amgen, Turningpoint Therapeutics, Relay Therapeutics Other Relationship: Medscape, Clinical Care Options

At the start of a new year, many physicians don't feel burned out, they feel unsettled.In this January Reset re-air, I'm bringing back my conversation with Dr. Cindy Dafashy, a family medicine physician who opened her direct primary care practice directly out of residency.This episode isn't about how quickly she launched or whether her path should be copied. It's about the distinction she names so clearly between being clinically prepared and actually feeling ready.Dr. Dafashy reflects on learning medicine inside a culture designed primarily for physicians, then realizing that patients don't live inside that world at all. She shares how shifting away from medical language and toward patient-centered communication changed not just her practice, but her sense of alignment as a physician.You'll also hear her talk about boundaries and how she set expectations early, how she framed access without over-promising, and how she protected her energy before burnout ever took hold.This episode pairs closely with the free January reflection worksheet, Is DPC Right for You?, especially if you're navigating early-career uncertainty or wondering whether something that looks “right” on paper actually feels sustainable.As you listen, notice what resonates and what creates tension. Those reactions are the point.January Reset Invitation Download the free January worksheet, Is DPC Right for You?, and answer just one prompt after this episode. One sentence is enough.Get the FREE workbook to go along with our January RESET series HERE. Learn how Zion HealthShare can pair with DPC to protect patients and physicians without returning to traditional insurance. Read more in the Toolkit, our DPC magazine, today.  If hiring feels like one of the most intimidating parts of growing your DPC practice, read the Winter issue of The Toolkit, our DPC Magazine that includes an educational, step-by-step hiring guide from the Cooperative of American Physicians designed to replace guesswork with clarity. What do you want MORE of in your practice this year? Download the January worksheet HERE for free today! Leave Maryal a voicemail @ https://mydpcstory.com/contactSupport the showGET your FREE MONTHLY BUSINESS TOOL DOWNLOAD Become A My DPC Story PATREON MEMBER! SPONSOR THE PODMy DPC Story VOICEMAIL! DPC SWAG!FACEBOOK * INSTAGRAM * LinkedIn * TWITTER * TIKTOK * YouTube

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/history

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/east-asian-studies

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/biography

This episode is a homecoming!!!As part of our January Reset Series, we're re-airing a powerful conversation with four physicians from three specialties who each share a one-year update on their Direct Primary Care journeys.In this episode, you'll hear from:• Dr. Christina Much and Dr. Jake Much (Family Medicine) founders of Defiant DPC who are sharing about growth beyond expectations and how they planned maternity leave without panic• Dr. Deepti Mundkur (Internal Medicine) will be reflecting on time, advocacy, mentorship, and designing a practice aligned with life• Dr. Lauren Hughes (Pediatrics & Lactation) will be discussing boundaries, parenting while practicing medicine, and building community-rooted careWhether you are in residency, early career, actively considering DPC, or already open and asking how do I protect my energy and build something sustainable, this episode is for you.These physicians aren't sharing finished stories - they're sharing living ones.And January is a reminder that it's okay to pause, reassess, and realign whether you're just beginning or years into practice.Take a breath.You're not behind.You're allowed to build something that lasts.What to Especially Listen For:• How growth sometimes comes faster than expected and how to respond without burning out• How maternity leave, parenting, and practice ownership can coexist• How advocacy becomes possible when time is no longer rationed• How workflows, boundaries, and systems continue to evolve after opening• How DPC allows doctors to practice medicine that matches their values and not just their training

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/new-books-network

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices

Hawaii Matters, Hana Hou is a listen back with excerpts featuring past guests and this episode includes:Kasey Crispin, Communications Lead – Hawai'i 'Ulu Cooperative / Local Farming, Agriculture, Sustainability Kasey Crispin, Communications Lead with the Hawaii ‘Ulu Cooperative, shares her personal experience as a Hawaii Island farmer on the rewards and challenges of stewarding the land that focuses on breadfruit or ‘ulu, as well as other canoe crops. October is “Farm to School Month” in Hawaii and one way to familiarize students, educators, and food service staff on the versatility of ‘ulu, pala'ai, kalo, and ‘uala is through their ongoing “Ho'olili ‘Ai” program and “Farm to School Sampler Boxes”. She also shares on agroforestry and how one ‘ulu plant can make a difference. Kathy With a K is your host. (original air date: October 12, 2025)"Hawaii Matters", a public service community program that airs on Sundays at 6:30 a.m. Hawaii across ⁠Pacific Media Group Oahu⁠ radio stations:⁠ KDDB 102.7 Da Bomb⁠ |⁠ KQMQ HI93⁠ | ⁠KUMU 94.7 KUMU⁠ | ⁠KPOI 105.9 The Wave⁠To be featured or for inquiries on "Hawaii Matters", please email: kathywithak@1059thewavefm.com

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/japanese-studies

Cooperative Evangelist: Kagawa Toyohiko and His World, 1888-1960 (University of Hawai'i Press, 2025) by Bo Tao uncovers the extraordinary world of a Japanese man who was once described as the “Saint Francis” or the “Gandhi” of Japan. A renowned religious figure on the world stage, Kagawa Toyohiko (1888–1960) received wide acclaim for his work as a street preacher in the slums of Kobe as well as his espousal of nonviolent methods of social reform. His reputation as a pacifist figure, however, rested uneasily with his wartime actions, which became increasingly supportive of the Japanese government and its expansionist policies. Reluctant to speak up against Japan's increasing aggression in the late 1930s, he emerged as a full-blown apologist during the Pacific War, appearing on several Radio Tokyo broadcasts as a propagandist defending the interests of the state. Adopting a transnational approach that accounts for the rapid flow of information between Japan and the United States, Bo Tao examines the career of Kagawa as it unfolded within the context of the wars, imperialism, and economic depression of the early to mid-twentieth century. Using official documents and personal correspondence that have received scant attention in previous works, Tao reveals, for the first time at this level of detail, the extent of Kagawa's cooperative relationship with the Japanese government, as well as the ways in which his idealized image was carefully constructed by his ardent missionary supporters. This book provides a window into the global dimensions of broader cultural shifts during the interwar period, such as the rise of Christian internationalism and the Depression-era popularity of cooperative economics. Offering a holistic and nuanced exploration of the tensions resulting from Kagawa's hybrid identity as a Japanese Christian, Cooperative Evangelist adds a new layer to our understanding of religion, empire, and politics in the shaping of social and international relations. Bo Tao is Lecturer in the College of Liberal Arts and Sciences at Chiba University in Chiba, Japan. His research interests include global history, U.S.-Japan relations, religion and politics, modern Japanese history, and the history of Christianity. Shatrunjay Mall is a PhD Candidate in the Department of History at the University of Wisconsin–Madison. He works on transnational Asian history, and his dissertation explores intellectual, political, and cultural intersections and affinities that emerged between Indian anti-colonialism and imperial Japan in the twentieth century. Learn more about your ad choices. Visit megaphone.fm/adchoices Support our show by becoming a premium member! https://newbooksnetwork.supportingcast.fm/christian-studies

What if every staff member at your utility felt confident answering energy questions? In this episode, Benton PUD's Jodi Henderson shares how its Empowered program turns staff into energy pros through training built on employee needs. Find out more about the program at bentonpud.org/empowered. Notes: Filmed at NWPPA's Northwest Innovations in Communications conference.

Ready to jump start classroom discourse in your math class in 2026? Get your students eagerly discussing math with these active teaching strategies!Enjoy this replay of: Episode #133 Active Teaching Strategies That Actually Spark Student Discussion to find out the best teaching strategies to engage your students in mathematical discourse!Inside you'll learn: ✅ Why passive instruction is killing engagement ✅ 3 go-to talk strategies you can use tomorrow ✅ Cooperative teaching strategies that build confidence and collaboration ✅ What NOT to do if you want students to participateLet's talk. Send me a message with your email and I'll get back to you!This podcast is a member of the Teach Better Podcast Network. Better Today. Better Tomorrow. And the Podcasts to Help You Get There.Connect with Kristen: Follow on Instagram @moorethanjustx Join the Facebook Community: The Modern Math Teachers Movement More About the Modern Math Teacher Podcast Kristen Moore, classroom teacher and instructional coach at Moore Than Just X, empowers modern secondary math teachers to transform the student experience with the strategies and the confidence to implement project-based learning, mastery-based assessment, and student engagement strategies in their classrooms. Whether you're a math education newbie or a seasoned veteran, you'll find something new and inspiring in every episode. You're already a listener, why not join the Movement inside ✨The Modern Math Teachers Movement Facebook group. Join the community of math teachers who are not afraid to shake things up and make math class the best part of the day for our students. So tune in each Tuesday, have some fun, and let's elevate our math teaching game together!*Amazon orders may provide a small affiliate payout at no extra cost to you. These payouts help keep the podcast free for all!

For episode 232, I'm excited to welcome Joshua Dávila, a longtime organizer, writer, and builder at the intersection of progressive politics and crypto. Josh is the host of The Blockchain Socialist podcast, the author of Blockchain Radicals, and a core contributor to Bread Cooperative, a worker-owned collective building real financial tools rooted in solidarity, not hype.In today's episode you'll learn:

Hi there, Phil and Maude here. You may notice that we haven't done a holiday post here. Since we write about peace all year round, and that is what we hope for, we will just say: Have a wonderful holiday … The Secret to Peaceful Relationships is Cooperative Interaction Read More »

New @greenpillnet pod out today!

Tune in to this exciting conversation with Meagan Alderton from the DC Special Education Cooperative to hear how they are creating systems where students with disabilities thrive. Meagan shares powerful strategies from successful DC schools, explaining why the Multi-Tiered Systems of Support (MTSS) framework is "just how you do school." Listen in for essential leadership advice that can help drive genuine change in your school.   Access the full podcast transcript at https://bit.ly/5MinsWithDCCoop

In this episode of Rocks to Roots, Hilary and Duane sit down with Michael Townshend of Wildland Cooperative for an inspiring conversation about the challenges and rewards of running a regenerative farm on Green Bluff, Washington.From cultivating vegetables and Christmas trees to brewing beer and building a community hub, Michael shares the mission behind Wildland Co-op and the values that guide their work. They discuss the importance of sustainable practices, supporting local food systems, and how the co-op is creating space for connection and education.Whether you're passionate about farming, local food, or the future of cooperative business models, this episode highlights the heart and hard work behind one of Spokane's most community-driven farms.Learn more about Wildland Cooperative at: https://www.wildland.coop/

When you walk into a legislator's office, will your story stick or slip away? In this episode, Inland Power & Light's Andy Barth shares how utilities can move beyond numbers to craft stories lawmakers care about.Notes: Filmed at NWPPA's Northwest Innovations in Communications conference.

In this special episode of The EV Ready Podcast, hosts Justin Ries and John Gilbrook talk with Nick Trout from Sourcewell to explore how cooperative purchasing helps state and local governments, schools, and nonprofits streamline EV and energy management projects while cutting costs and reducing risk. How Cooperative Purchasing Accelerates EV Charging and Energy Management for Public Entities Using Sourcewell's cooperative purchasing model, public entities can bypass lengthy, resource‑intensive RFP processes and move faster on critical EV and energy management projects. By leveraging competitively solicited contracts like EVready's Sourcewell award, agencies gain access to pre-vetted vendors, transparent pricing, and contract terms that already meet procurement and compliance requirements.​ For state and local governments, school districts, and nonprofits, this structure: Reduces administrative burden Shortens procurement timelines Lowers the risk associated with selecting new EV and energy management partners Instead of writing their own complex solicitations, buyers can “piggyback” on Sourcewell's competitively bid contracts, allowing them to focus on planning and implementing EV charging infrastructure and fleet electrification strategies that align with budget and sustainability goals

Looking for something to give to the gamer in your life? Dan is back with a rundown of gift ideas for the holidays. http://www.podtrac.com/pts/redirect.mp3/traffic.libsyn.com/majorspoilers/MunchkinMarvel.mp3 Direct Download You can subscribe to the RSS feed here. Subscribe via Apple Podcasts Subscribe to the Major Spoilers Podcast Network Master Feed! Major Spoilers Podcast Network Master Feed RSS Feed Show your thanks to Major Spoilers for this episode by becoming a Major Spoilers Patron at http://patreon.com/MajorSpoilers. It will help ensure Munchkin Land continues far into the future! Join our Discord server and chat with fellow Spoilerites! (https://discord.gg/jWF9BbF) Contact us at podcast@majorspoilers.com GIFT GUIDE Some small great Stocking Stuffers Flip 7 (And Be SURE TO GET GRINCH Edition-- WalMart Exclusive) Mountain Goats Ruins Fight 5 Co-Operative style and/or Family The Lord of the Rings Trick Taking Game The Lord of the Rings Fate of the Fellowship Hot Streak -- Think Ready set bet but even lighter fun For your Heavy Game lovers in your group Speakeasy Shackleton Base Galactic Cruise FFG announced all the releases for 2026 for Marvel Champions WizKids will release more Marvel Remix in April '26 with Marvel Remix:The Cosmos ($20) Remix is the Marvel skinned Fantasy realms a drafting game with optimizing your hand based on scoring of the cards. Leder Games will release two small expansions for Root. The Squires and Disciples Deck ( Aug '26 $10) The Homeland Hireling Pack (Aug '26  $20) CROWD FUNDING KICKSTARTER Mystery Science Theater 3000: The Game Queen Carrom and Crokinole To Go The Great Library by Vital Lacerda with Art by Ian O'Toole GAMEFOUND Arydia 2nd print The Witcher Legacy Radiance Dragon Eclipse:The Grand Quest   #gaming #gamers #giftguide #munchkin 

Send us a textIn this special year-end episode, host Donna DiMaggio Berger and producer Claude Jennings cut through the noise and reveal the real shifts that changed how community associations operate—from high-stakes legal challenges to the everyday pressures managers and volunteer directors face on the ground. This isn't just a recap. It's a reality check.Donna and Claude revisit their most talked-about conversations of the year, including:Building a company worth selling — insights from a top property management leader on culture, systems, and long-game strategy.A former Florida Condominium Ombudsman who demystified what meaningful government support should look like.A Shark Tank founder whose flood-ready product offers communities a rare gift: storm prep that actually works.They also spotlight two sleeper-hit episodes that delivered outsized value:A pest control strategist explaining modern, low-toxicity treatments and how understanding pest behavior can save buildings money, time, and disruption.An etiquette expert who reframed neighbor conflict as a communication skill—not a personality flaw—and showed how diplomacy, positive intent, and smart email habits can avert half your headaches.A guest who revealed the common gaps in most communities' screening and security protocols and how to address them.One of the year's most sobering discussions came from immigration attorney Ira Kurzban, who explained why every association needs a well-defined ICE response protocol—long before it's needed. And yes, Donna and Claude revisit the throughline in almost every episode: Artificial Intelligence. Is the guest's industry going to be impacted by AI, what can AI do well, what it can't, and why “AI wrote it” is not a substitute for human judgment.If your community is ready to shift from reactive crisis management to proactive prevention, this 2025 wrap-up pulls together the year's most powerful lessons into clear, actionable takeaways you can put to work immediately—whether you're a board member, manager, or industry professional.Related Links:Firm Bio: Donna DiMaggio BergerPodcast: Take It To The Board's 100th Episode Milestone— From Building Castle Group to Industry Icon: A Conversation with James DonnellyPodcast: Important Insights from Florida's Former Condominium OmbudsmanPodcast: Storm-Ready in Seconds: How Shark Tank's StormBag Is Changing Hurricane and Severe Weather PrepPodcast: Monsters In The Walls — Pest Control Truths for Condos and HOAsPodcast: Mind Your Manners: Restoring Respect in Condo, Cooperative and HOA CommunitiesPodcast: Screening Vendors and Service People for Enhanced Security

This time, we continue our discussion of RPGs by suggesting Role Playing Games that share popular boardgaming mechanisms, as well as giving Tom tips for getting a game started. Plus, we have a new Tale of Boardgaming Horror, and we close the show with some Roses, Thorns, and Hula Hoops. 00:50 - A Story About Mail 02:22 - Eric at PAX Unplugged (inc. Hot Streak) 06:50 - Gift Guides, Dice Tower West and East 08:02 - RPGs for Boardgame Fans (detailed notes below) 37:55 - Tale of Boardgaming Horror 43:03 - Fromaggio 48:35 - Gnomic Parlament 52:13 - Carnuta 54:49 - Magic Number 11 56:54 - Insurrect10n -- Julie's Notes Where to go to get core book pdfs? DriveThruRPG https://www.drivethrurpg.com/en/  Itch.io https://itch.io/  Cooperative play (yes the overwhelming majority of TTRPGs are cooperative) some extra cooperative leaning  Heckin' Good Doggos https://www.drivethrurpg.com/en/product/405426/heckin-good-doggos  Teatime Adventures https://www.snowbrightstudio.com/teatime-adventures  Dice rolling - Also many many many ttrpgs use dice. Here are some examples D20 - D&D/Pathfinder https://www.dndbeyond.com/?srsltid=AfmBOorCdKoS-xSfI4e05Us81YGA4tHt8CmmaOWNN-9VTcnsAfXS5pBS, https://paizo.com/pathfinder  d100 (percentile): Call of Cthulhu https://www.chaosium.com/call-of-cthulhu-rpg/  Symbol-based dice: FFG Star Wars. https://www.fantasyflightgames.com/en/starwarsrpg/ , Fudge dice: Fate  https://evilhat.com/product/fate-core-system/    Area control Beak, Feather, & Bone https://possible-worlds-games.itch.io/bfb  Faction/War Song of Ice and Fire RPG http://www.drivethrurpg.com/product/101026/A-Song-of-Ice-and-Fire-Roleplaying-A-Game-of-Thrones-Edition  Mutant: Year Zero https://www.drivethrurpg.com/product/139453/MUTANT-Year-Zero--Roleplaying-At-The-End-Of-Days  Numenera: Destiny https://www.drivethrurpg.com/product/240655/Numenera-Destiny  Coyote and Crow https://www.allplay.com/board-games/coyote-and-crow-the-roleplaying-game/    Action points -  Level Up D&D PbtA  Using Action points Feng Shui https://atlas-games.com/fengshui  C&S: Rebirth  Mythras    Deck builder/Bidding Ok not really but Redigo is "Hand Management"  https://letsplayredigo.com/  Games using a standard deck of cards Castle Falkenstein https://www.drivethrurpg.com/en/product/2370/castle-falkenstein  Games using a custom or proprietary card deck - mostly they are being used instead of dice Dragonlance: Fifth Age https://www.drivethrurpg.com/en/product/186462/dragonlance-fifth-age-dramatic-adventure-game-saga  Clockwork Dominion https://www.drivethrurpg.com/en/product/489608/courier-repacked  My Closest Pick Torg Eternity:A Thousand Faces of Adventure http://torg-gamereference.com/    Pick up and Deliver Solo/journal: Courier https://www.drivethrurpg.com/en/product/489608/courier-repacked   Delivered! https://www.drivethrurpg.com/en/product/441018/delivered-a-solo-journaling-rpg  One shot Delivery Dragons https://shardsofblue.itch.io/delivery-dragons   Worker Placement? Become a GM Questions? Tales of Horror? tom@dicetower.com

In this episode, Cameron sits down with Brett Bruggeman, Executive Vice President and COO of Land O'Lakes, a 104-year-old, $16B cooperative spanning dairy foods, animal nutrition, and crop inputs. Brett shares how Land O'Lakes manages scale across 20 business units, supports more than 4,000 cooperative owners, and touches half of America's farmland.He and Cameron dig into the cooperative model, growth challenges in shrinking markets, how the company is driving new productivity for farmers, and their bold new initiative that partners with retail owners to invest in late-stage ag-tech. Brett also talks about outside-in thinking, the power of data, how to stay ahead of the customer, and why the future of agriculture requires both AI and human EQ.If you're a COO navigating large-team complexity, shifting markets, or innovation inside a legacy organization, this conversation is a masterclass in clarity, discipline, and strategic focus.Timestamped Highlights00:00 Brett and Cameron kick off the conversation (with a quick cameo from Brett's comms lead, John).01:03 How Brett discovered the podcast and the purpose of “the COO story.”03:30 Land O'Lakes overview: 104-year history, cooperative structure, and national footprint.07:14 The company's roots: dairy farmers searching for a market for cream.08:26 How Land O'Lakes evolved into dairy, animal nutrition, and crop inputs.10:24 Purina brand clarification: Land O'Lakes vs. Nestlé internationally.10:44 Revenue breakdown across business units.12:00 How Brett avoids getting pulled into every detail while leading a massive enterprise.14:10 How outside-in thinking reshaped corporate strategy.15:17 The “vital few” → the three-or-four priorities that guide the entire company.16:49 The six transformation “big bets.”18:46 Becoming a data-first company: insights, segmentation, and new markets.20:29 The strategic questions Land O'Lakes uses to break stagnation.22:45 Their stance on hybrid work and why face-to-face still matters.25:05 Growth challenges: farmers under pressure, shrinking markets, and opportunities.26:05 Introducing AgRogue: the new retail growth fund (70–100M) to invest in late-stage ag-tech.27:39 Why partnering with retail owners creates stronger market access.28:17 What a cooperative actually is and how it differs from other business models.31:39 How 4,000 owners create loyalty, but not complacency.33:31 Why aligning retail owners with Land O'Lakes creates predictable innovation adoption.36:51 How AI and predictive models are transforming supply chain, waste, and productivity.38:37 Three AI goals: target growth, eliminate waste, improve customer experience.40:55 How Land O'Lakes approaches AI responsibly (and without getting “over their skis”).42:37 What Brett is working on personally as a leader: presence, change management, results.47:28 Advice to his younger self: ask better questions, seek mentors, take international roles.Resources & MentionsPurina (livestock feed brand)WinField (crop inputs brand)Microsoft (AI and data initiatives)AgRogue (Land O'Lakes + retail owner growth fund)Radicle (ag-tech investment partner)Circana (retail data source, referenced as...

October 23rd, 2024John Kelly confirms to the Atlantic that Trump called military and veterans suckers and losers; the Georgia Supreme Court unanimously upholds the block of the State Election Board's last minute rule changes; US officials confirm the smear of Tim Walz was Russian propaganda; Rudy has been ordered to hand his property over to Ruby Freeman and Shaye Moss; judges have rejected the RNC lawsuits challenging some overseas ballots in Michigan and North Carolina; the former Abercrombie & Fitch CEO has been charged with sex trafficking over a dozen victims; a Philadelphia man has been charged for making gruesome threats against a person recruiting poll watchers; the Army has been ordered to release the report of the Trump incident at Arlington National Cemetery; and Allison and Dana deliver your Good News. Guest:Timothy SnyderOn Freedom by Timothy SnyderOther Books (timothysnyder.org)Twitter - @TimothySnyderSubstack - Thinking About... Our Donation LinksNational Security Counselors - DonateMSW Media, Blue Wave California Victory Fund | ActBlueWhistleblowerAid.org/beansFederal workers - feel free to email AG at fedoath@pm.me and let me know what you're going to do, or just vent. I'm always here to listen. Find Upcoming Actions 50501 Movement, No Kings.org, Indivisible.orgDr. Allison Gill - Substack, BlueSky , TikTok, IG, TwitterDana Goldberg - BlueSky, Twitter, IG, facebook, danagoldberg.comCheck out more from MSW Media - Shows - MSW Media, Cleanup On Aisle 45 pod, The Breakdown | SubstackShare your Good News or Good TroubleMSW Good News and Good TroubleHave some good news; a confession; or a correction to share?Good News & Confessions - The Daily Beanshttps://www.dailybeanspod.com/confessional/ Listener Survey:http://survey.podtrac.com/start-survey.aspx?pubid=BffJOlI7qQcF&ver=shortFollow the Podcast on Apple:The Daily Beans on Apple PodcastsWant to support the show and get it ad-free and early?The Daily Beans | SupercastThe Daily Beans & Mueller, She Wrote | PatreonThe Daily Beans | Apple Podcasts Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.